Abstract:Pluripotency is established through genome-wide reprogramming during mammalian pre-implantation development, resulting in the formation of the naive epiblast. Reprogramming involves both the resetting of epigenetic marks and the activation of pluripotent-cell-specific genes such as Nanog and Oct4 (also known as Pou5f1). The tight regulation of these genes is crucial for reprogramming, but the mechanisms that regulate their expression in vivo have not been uncovered. Here we show that Nanog--but not Oct4--is monoallelically expressed in early pre-implantation embryos. Nanog then undergoes a progressive switch to biallelic expression during the transition towards ground-state pluripotency in the naive epiblast of the late blastocyst. Embryonic stem (ES) cells grown in leukaemia inhibitory factor (LIF) and serum express Nanog mainly monoallelically and show asynchronous replication of the Nanog locus, a feature of monoallelically expressed genes, but ES cells activate both alleles when cultured under 2i conditions, which mimic the pluripotent ground state in vitro. Live-cell imaging with reporter ES cells confirmed the allelic expression of Nanog and revealed allelic switching. The allelic expression of Nanog is regulated through the fibroblast growth factor-extracellular signal-regulated kinase signalling pathway, and it is accompanied by chromatin changes at the proximal promoter but occurs independently of DNA methylation. Nanog-heterozygous blastocysts have fewer inner-cell-mass derivatives and delayed primitive endoderm formation, indicating a role for the biallelic expression of Nanog in the timely maturation of the inner cell mass into a fully reprogrammed pluripotent epiblast. We suggest that the tight regulation of Nanog dose at the chromosome level is necessary for the acquisition of ground-state pluripotency during development. Our data highlight an unexpected role for allelic expression in controlling the dose of pluripotency factors in vivo, adding an extra level to the regulation of reprogramming.

Nanog safeguards early embryogenesis against global activation of maternal β-catenin activity by interfering with TCF factors

Knockdown of zebrafish Nanog increases primordial germ cells during early embryonic development

Maternal xNorrin, a canonical Wnt signaling agonist and TGF-β antagonist, controls early neuroectoderm specification in Xenopus.

Nanog, Pou5f1 and SoxB1 activate zygotic gene expression during the maternal-to-zygotic transition

Nanog safeguards pluripotency and mediates germline development

Nanos2 Promotes Differentiation of Chicken (gallus Gallus) Embryonic Stem Cells to Male Germ Cells

GATA-1 directly regulates Nanog in mouse embryonic stem cells

The Amotl2 Gene Inhibits Wnt/β-catenin Signaling and Regulates Embryonic Development in Zebrafish.

Maternal RNF114-mediated target substrate degradation regulates zygotic genome activation in mouse embryos

Progress in nanos Gene

Multiple phases in regulation of Nanog expression during pre-implantation development

Control of ground-state pluripotency by allelic regulation of Nanog

Tob1 Controls Dorsal Development of Zebrafish Embryos by Antagonizing Maternal Beta-Catenin Transcriptional Activity

Zfp281 Mediates Nanog Autorepression Through Recruitment of the Nurd Complex and Inhibits Somatic Cell Reprogramming

Comprehensive Maturity of Nuclear Pore Complexes Regulates Zygotic Genome Activation

Nanog regulates molecules involved in stemness and cell cycle-signaling pathway for maintenance of pluripotency of P19 embryonal carcinoma stem cells

Cross-regulation of the Nanog and Cdx2 Promoters

Kzp Controls Canonical Wnt8 Signaling to Modulate Dorsoventral Patterning During Zebrafish Gastrulation

Jun NH 2 -Terminal Kinase (JNK) Prevents Nuclear Β-Catenin Accumulation and Regulates Axis Formation in Xenopus Embryos

Maternal Inheritance of Nanog Ortholog in Blunt-Snout Bream.

NR5A2 connects zygotic genome activation to the first lineage segregation in totipotent embryos